Related Experiment Video

Updated: Aug 20, 2026

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish
06:15

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish

Published on: August 16, 2024

[Cardiovascular manifestations of thyrotoxicosis and thyroid dysfunction caused by amiodarone]

József Simkó1, Kitti Barta, Zoltán Szabó

  • 1Semmelweis Kórhaz, I. Belgyógyászati Osztály, Miskolc. sjozs74@hotmail.com

Orvosi Hetilap
|January 11, 2005
PubMed

Insights

Thyroid hormones significantly impact cardiovascular health, affecting heart rate and blood pressure. Amiodarone, an anti-arrhythmic drug, can disrupt thyroid function, leading to thyrotoxicosis or hypothyroidism.

Area of Science:

  • Endocrinology
  • Cardiology
  • Pharmacology

Context:

  • Thyroid hormones profoundly influence cardiovascular hemodynamics, affecting the myocardium, circulation, and nervous system.
  • Subclinical hyperthyroidism, characterized by low TSH and normal thyroid hormones, presents with cardiovascular changes like increased heart rate and altered blood pressure.
  • Thyrotoxicosis can worsen existing heart conditions or cause symptoms in individuals with structurally normal hearts.

Purpose:

  • To review the cardiovascular manifestations of thyrotoxicosis and amiodarone-induced thyroid dysfunction.
  • To highlight the complex interplay between thyroid hormones and cardiovascular health.
  • To discuss the impact of amiodarone on thyroid function and its clinical implications.

Summary:

  • Thyrotoxicosis affects heart rate, contractility, blood pressure, and vascular resistance, potentially leading to arrhythmias, heart failure, and hypertension.
  • Amiodarone, a widely used anti-arrhythmic, can cause various thyroid dysfunctions, including overt thyrotoxicosis and hypothyroidism, even at low doses.
  • The drug's side effects extend to multiple organs, necessitating careful monitoring of thyroid function in patients treated with amiodarone.

Impact:

  • Understanding these interactions is crucial for managing patients with cardiac conditions and thyroid dysfunction.
  • This knowledge aids in the appropriate use of amiodarone and the early detection of associated thyroid complications.
  • Improved patient outcomes through comprehensive management of cardiovascular and thyroid-related issues.

Related Concept Videos

Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...